{"url_path":"/sec/renx/8-k/2026-06-15/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-15","source_url":"https://www.sec.gov/Archives/edgar/data/1959023/0001213900-26-068872-index.html","accession_number":"0001213900-26-068872","cik":"0001959023","ticker":"RENX","issuer_name":"RenX Enterprises Corp.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1959023/0001213900-26-068872-index.html","primary_entity_key":"0001959023","primary_entity_name":"RenX Enterprises Corp."},"word_count":851,"has_tables":true,"body_markdown":"****\n\n** **\n\n**Item 5.07. Submission of Matters to a Vote\nof Security Holders.**\n\n \n\nAt the Annual Meeting,\nthe stockholders voted on eight proposals, each of which is listed below and described in more detail in the Company’s Proxy Statement.\nWith respect to each proposal, holders of the Company’s Common Stock were entitled to cast one vote per share of Common Stock held\nas of the close of business on the record date of April 13, 2026 (the “Record Date”). On the Record Date there were 2,499,293\nshares of the Company’s Common Stock issued and outstanding and entitled to vote at the Annual Meeting.\n\n \n\nThe following are the\nfinal results of voting on each of the proposals presented at the Annual Meeting:\n\n \n\n**Proposal 1 — Election of Class III\nDirectors Proposal**\n\n \n\nThe stockholders elected each of James D. Burnham\nand Peter G. DeMaria to serve as a Class III director until the 2029 Annual Meeting of Stockholders, based on the votes below:\n\n \n\n  \nFor \nWithheld \nBroker\nNon-Votes\n\nJames D. Burnham \n556,017 \n15,984 \n427,279\n\nPeter G. DeMaria \n555,947 \n16,054 \n427,279\n\n \n\n**Proposal 2 — Auditor Ratification\nProposal**\n\n** **\n\nThe stockholders ratified the appointment of M&K\nCPAS PLLC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, based on\nthe votes below:\n\n** **\n\n**Votes For**\n \n**Votes Against**\n \n**Abstentions**\n \n**Broker Non-Votes**\n\n837,316\n \n152,570\n \n9,393\n \n-\n\n \n\n**Proposal 3 — Additional February Warrant Exercise Proposal**\n\n \n\nThe stockholders approved, pursuant to Nasdaq\nRule 5635(d), the issuance of up to 862,335 shares of the Company’s Common Stock upon the exercise of certain warrants which were\nissued to investors in connection with the Company’s private placement offering that closed on February 17, 2026, based on the votes\nlisted below:\n\n \n\n**Votes For**\n \n**Votes Against**\n \n**Abstentions**\n \n**Broker Non-Votes**\n\n546,161\n \n22,436\n \n3,404\n \n427,279\n\n \n\n**Proposal 4 —\nInitial April Note and Second April Note Conversion Proposal**\n\n** **\n\nThe stockholders approved,\npursuant to Nasdaq Rule 5635(d), of the issuance of up to 26,779,029 shares of the Company’s Common Stock upon the conversion of\nsenior convertible notes (collectively, the “April Notes”) in the aggregate principal amount of up to $13.0 million (assuming\nsuch April Notes accrue interest at 10% for 12 months and that the conversion price is reduced to the floor price), which April Notes\nhave been, or may in the future be, issued to investors pursuant to a Securities Purchase Agreement dated April 30, 2026 (the “April\nPurchase Agreement”), based on the votes below:\n\n \n\n**For**\n \n**Against**\n \n**Abstain**\n \n**Broker Non-Votes**\n\n542,888\n \n26,661\n \n2,452\n \n427,279\n\n \n\n4\n\n \n\n**Proposal 5***–\n**Additional April Note Conversion Proposal***\n\n \n\nThe stockholders approved,\npursuant to Nasdaq Rule 5635(d), of the issuance of up to an additional 179,213,485 shares of the Company’s Common Stock upon the\nconversion of additional April Notes in the aggregate principal amount of up to $87.0 million (collectively, the “Additional April\nNotes”) (assuming such Additional April Notes accrue interest at 10% for 12 months and that the conversion price is reduced to the\nfloor price), which Additional April Notes may in the future be issued to investors pursuant to the April Purchase Agreement, based on\nthe votes below:\n\n \n\n**For**\n \n**Against**\n \n**Abstain**\n \n**Broker Non-Votes**\n\n539,231\n \n30,318\n \n2,452\n \n427,279\n\n \n\n**Proposal 6 - Reverse\nStock Split Proposal**\n\n** **\n\nThe stockholders approved\nan amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended, to, at the discretion of the Board,\neffect a reverse stock split with respect to the Company’s issued and outstanding Common Stock, at a ratio of 1-for-5 to 1-for-10\n(the “Range”), with the final ratio within such Range to be determined at the discretion of the Board and included in a public\nannouncement, based on the votes below:\n\n \n\n**For**\n \n**Against**\n \n**Abstain**\n \n**Broker Non-Votes**\n\n801,362\n \n193,585\n \n4,333\n \n0\n\n \n\n **Proposal 7***– **2023 Plan Amendment Proposal***\n\n \n\nThe stockholders approved\nan amendment to the Company’s 2023 Plan to (i) increase the number of shares of Common Stock authorized for issuance under the 2023\nPlan from 138,861 shares to 520,000 shares, and (ii) increase the total number of shares of Common Stock with respect to which awards\nmay be granted to any non-employee director in his or her capacity as a non-employee director in any single calendar year by 72,500 shares\nto 75,000 shares, based on the votes below:\n\n \n\n**For**\n \n**Against**\n \n**Abstain**\n \n**Broker Non-Votes**\n\n541,578\n \n28,484\n \n1,939\n \n427,279\n\n \n\n**Proposal 8– Adjournment Proposal**\n\n \n\nThe stockholders approved\nan adjournment of the Annual Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the\nevent there are not sufficient votes in favor of the Additional February Warrant Exercise Proposal, the Initial April Note and Second\nApril Note Conversion Proposal, the Additional April Note Conversion Proposal, the Reverse Stock Split Proposal or the 2023 Plan Amendment\nProposal, based on the votes below. However, the Company elected not to adjourn the Annual Meeting, as such an adjournment was not necessary\nin light of the approval of the Additional February Warrant Exercise Proposal, the Initial April Note and Second April Note Conversion\nProposal, the Additional April Note Conversion Proposal, the Reverse Stock Split Proposal and the 2023 Plan Amendment Proposal at the\nAnnual Meeting.\n\n \n\n**For**\n \n**Against**\n \n**Abstain**\n \n**Broker Non-Votes**\n\n803,648\n \n179,085\n \n16,546\n \n0"}